{"id":28279,"date":"2025-07-24T19:30:22","date_gmt":"2025-07-24T19:30:22","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/it\/?page_id=28279"},"modified":"2025-07-30T11:06:42","modified_gmt":"2025-07-30T11:06:42","slug":"dichiarazione-informativa-non-finanziaria","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria","title":{"rendered":"Dichiarazione informativa non finanziaria"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"28279\" class=\"elementor elementor-28279\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0b615cc e-flex e-con-boxed e-con e-parent\" data-id=\"0b615cc\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d63cc22 elementor-widget elementor-widget-spacer\" data-id=\"d63cc22\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-45881204 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"45881204\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7878a223\" data-id=\"7878a223\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6753a287 elementor-widget elementor-widget-text-editor\" data-id=\"6753a287\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>(Estado de informacion No Financiera &#8211; EINF, in Spanish)<\/p>\n<p>In conformit\u00e0 con la Legge 11\/2018 sulla Dichiarazione Informativa Non Finanziaria e sulla Diversit\u00e0, Neuraxpharm Pharmaceutical S.L.U. (gi\u00e0 Laboratories Lesvi S.L.U.) redige annualmente la propria Dichiarazione Informativa Non Finanziaria, seguendo le raccomandazioni e le indicazioni stabilite dalla suddetta Legge 11\/2018.<\/p>\n<p>La relazione include informazioni sulle questioni ambientali, sociali e del personale, sui diritti umani, sulla lotta alla corruzione e alla concussione e sull&#8217;impatto dell&#8217;organizzazione sulla societ\u00e0. Per ciascuno di questi temi, vengono descritte le politiche e le azioni sviluppate, nonch\u00e9 i rischi identificati e derivanti dallo sviluppo dell&#8217;attivit\u00e0 dell&#8217;azienda. La relazione \u00e8 stata redatta in conformit\u00e0 ai principi di comparabilit\u00e0, attendibilit\u00e0, materialit\u00e0 e rilevanza stabiliti dalla citata Legge 11\/2018.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-3ccfdff8 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3ccfdff8\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-cbb8247\" data-id=\"cbb8247\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5755ba53 elementor-widget elementor-widget-button\" data-id=\"5755ba53\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131305\/informe-einf-neuraxpharm-pharmaceuticals-2023.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Relazione Informativa Non Finanziaria 2023<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-6f1a4600 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6f1a4600\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-32e33344\" data-id=\"32e33344\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-69f9daa elementor-widget elementor-widget-button\" data-id=\"69f9daa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131248\/informe-einf-laboratorios-lesvi-2022.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Relazione Informativa Non Finanziaria 2022<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-444f7754 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"444f7754\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-4b602733\" data-id=\"4b602733\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-439e14e1 elementor-widget elementor-widget-button\" data-id=\"439e14e1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131241\/informe-einf-laboratorios-lesvi-2021.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Relazione Informativa Non Finanziaria 2021<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>(Estado de informacion No Financiera &#8211; EINF, in Spanish) In conformit\u00e0 con la Legge 11\/2018 sulla Dichiarazione Informativa Non Finanziaria e sulla Diversit\u00e0, Neuraxpharm Pharmaceutical S.L.U. (gi\u00e0 Laboratories Lesvi S.L.U.) redige annualmente la propria Dichiarazione Informativa Non Finanziaria, seguendo le raccomandazioni e le indicazioni stabilite dalla suddetta Legge 11\/2018. La relazione include informazioni sulle questioni [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-28279","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Dichiarazione informativa non finanziaria - Neuraxpharm Italia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dichiarazione informativa non finanziaria\" \/>\n<meta property=\"og:description\" content=\"(Estado de informacion No Financiera &#8211; EINF, in Spanish) In conformit\u00e0 con la Legge 11\/2018 sulla Dichiarazione Informativa Non Finanziaria e sulla Diversit\u00e0, Neuraxpharm Pharmaceutical S.L.U. (gi\u00e0 Laboratories Lesvi S.L.U.) redige annualmente la propria Dichiarazione Informativa Non Finanziaria, seguendo le raccomandazioni e le indicazioni stabilite dalla suddetta Legge 11\/2018. La relazione include informazioni sulle questioni [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Italia\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-30T11:06:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria\",\"url\":\"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria\",\"name\":\"Dichiarazione informativa non finanziaria - Neuraxpharm Italia\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/#website\"},\"datePublished\":\"2025-07-24T19:30:22+00:00\",\"dateModified\":\"2025-07-30T11:06:42+00:00\",\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/it\/\",\"name\":\"Neuraxpharm Italia\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dichiarazione informativa non finanziaria - Neuraxpharm Italia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria","og_locale":"it_IT","og_type":"article","og_title":"Dichiarazione informativa non finanziaria","og_description":"(Estado de informacion No Financiera &#8211; EINF, in Spanish) In conformit\u00e0 con la Legge 11\/2018 sulla Dichiarazione Informativa Non Finanziaria e sulla Diversit\u00e0, Neuraxpharm Pharmaceutical S.L.U. (gi\u00e0 Laboratories Lesvi S.L.U.) redige annualmente la propria Dichiarazione Informativa Non Finanziaria, seguendo le raccomandazioni e le indicazioni stabilite dalla suddetta Legge 11\/2018. La relazione include informazioni sulle questioni [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria","og_site_name":"Neuraxpharm Italia","article_modified_time":"2025-07-30T11:06:42+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria","url":"https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria","name":"Dichiarazione informativa non finanziaria - Neuraxpharm Italia","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/it\/#website"},"datePublished":"2025-07-24T19:30:22+00:00","dateModified":"2025-07-30T11:06:42+00:00","inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/it\/dichiarazione-informativa-non-finanziaria"]}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/it\/#website","url":"https:\/\/www.neuraxpharm.com\/it\/","name":"Neuraxpharm Italia","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/pages\/28279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/comments?post=28279"}],"version-history":[{"count":13,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/pages\/28279\/revisions"}],"predecessor-version":[{"id":28482,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/pages\/28279\/revisions\/28482"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/media?parent=28279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}